Purchase Order W81K0225PA048
- Not listed
- The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is...
- The federal contract award HT940623P0100, valued at $91,029.00, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the provision of implementation services. This is a firm-fixed-price purchase order contract with no set-aside designation, indicating Haemonetics' competitiveness as a large, established provider of specialized medical equipment and services to government healthcare agencies. The contract includes the supply of...
- This is a $1,022.50 firm fixed-price purchase order awarded by the Defense Health Agency to Haemonetics Corporation, a leading medical technology company, for a post-thaw solution. The contract has no set-aside designation, indicating it was awarded on a full and open competitive basis. Haemonetics Corporation also holds a larger $3,824,433.60 Indefinite Delivery Contract with the Department of Veterans Affairs for procuring autotransfusion units and related medical equipment to support surgical...
- This $67,003.20 firm-fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract does not have a set-aside designation. The award is for the delivery of 0236-00 items as described in the contract, likely blood processing equipment and consumables. Haemonetics is an established medical device manufacturer that has received...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma supplies and services, for $30,688.30. The contract is for blood consumable supplies such as blood bags, tubing sets, reagents, and solutions. The award has an ultimate completion date of August 1, 2022 and does not utilize a set-aside. Haemonetics is the prime contractor and no subcontractors are identified. The DHA, which delivers integrated...
- This federal contract award is for the delivery of a NUTRIENT ADDITIVE SOLUTION FORMULA to the Defense Health Agency. The prime contractor is Haemonetics Corporation, a leading medical technology company headquartered in Boston, Massachusetts. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $46,615.22 and an ultimate completion date of September 30, 2025. The contract was awarded on a full and open competitive basis, with no set-aside designation. Haemonetics...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the delivery of Lab Analyzers. The contract has a ceiling value of $71,916.00 and an ultimate completion date of October 31, 2024. There is no set-aside designation, indicating Haemonetics competed effectively as a large, established supplier. The contract is part of Haemonetics' broader portfolio of medical device and equipment supply...
- Haemonetics Corporation was awarded a delivery order valued at $22,660 by a civilian federal agency with a place of performance in Boston, MA. This firm fixed-price delivery order was issued on January 1, 2025, with an ultimate completion date of May 31, 2025, and represents orders placed during the January through May 2025 period. The award was made on a full and open competitive basis with no set-aside designation applied. As a leading medical technology company specializing in blood and...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Haemonetics Corporation, a leading medical technology company based in Boston, Massachusetts. The $49,103.47 firm fixed-price purchase order is for #00236-00 RBC De-Glycerol Set 325ML, a laboratory supply and testing supply. The contract has no set-aside designation, indicating Haemonetics competed on an open, competitive basis. Haemonetics is an experienced federal contractor, having secured...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Haemonetics Corporation, doing business as Haemonetics, for an Automated Cell Processor. The $238,413.00 contract has a completion date of September 28, 2018. Haemonetics is a for-profit organization that provides blood and plasma supplies and services, including medical devices, consumables, and related services to federal agencies such as the Defense Health Agency, Department of Veterans Affairs, and...
The Defense Health Agency awarded a $81,976 purchase order to Haemonetics Corporation on August 12, 2025, for the procurement of a Haemonetics Bloodtrack Refrigerator, with completion targeted for September 30, 2025. This firm fixed-price contract was awarded on a full and open competitive basis with no set-aside designation. Haemonetics Corporation, a leading medical technology company headquartered in Boston, Massachusetts, specializes in blood and plasma management products and has been registered in the System for Award Management since 2002. The Bloodtrack Refrigerator represents part of Haemonetics' comprehensive blood management portfolio supplied to federal healthcare agencies. The company maintains significant contracting relationships across the Department of Defense healthcare system, the Department of Veterans Affairs, and the National Institutes of Health, providing critical medical equipment and consumables for blood collection, processing, transfusion, and hemostasis management. This award reflects the company's established position as a reliable supplier of advanced medical technologies to support clinical operations across federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.0k | 8/20/25 |